Videos about GBS

Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Richard A. Lewis, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
13:53 MIN
  • CIDP
  • GBS
  • MMN

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

DOWNLOAD PDF
IgG Levels and Wear Off Reflect Administration and Outcome
Carol L. Koski, MD
GBS/CIDP Foundation International
5:51 MIN
  • CIDP
  • GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
DOWNLOAD PDF
Incidence of GBS and CIDP Following Influenza Vaccination
Peter Donofrio, MD
Vanderbilt University Medical Center, Nashville, TN, USA
25:18 MIN
  • CIDP
  • GBS

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

DOWNLOAD PDF
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
David R. Cornblath, MD
Johns Hopkins University, Baltimore, MD, USA
7:23 MIN
  • GBS

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

DOWNLOAD PDF
NOW PLAYING
13:53
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

NOW PLAYING
5:51
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
NOW PLAYING
25:18
Incidence of GBS and CIDP Following Influenza Vaccination

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

NOW PLAYING
7:23
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

Our Experts on GBS

Kenneth C. Gorson, M.D.
Tufts University School of Medicine
Kenneth C. Gorson, M.D.
Kenneth C. Gorson, M.D.
Tufts University School of Medicine
  • GBS
Kenneth C. Gorson, M.D. is a Professor of Neurology in the Department of Neurology at St. ElizabethÔÇÖs Medical Center, Tufts University School of Medicine, in Boston.
Carol L. Koski, MD
GBS/CIDP Foundation International
Carol L. Koski, MD
GBS/CIDP Foundation International
  • CIDP
  • GBS
Dr. Koski is a retired Professor of Neurology from the University of Maryland School of Medicine and is currently a Director of the GBS/CIDP Foundation International.
Thomas Harbo, MD, PhD
Aarhus University Hospital in Aarhus, Denmark
Thomas Harbo, MD, PhD
Aarhus University Hospital in Aarhus, Denmark
  • CIDP
  • GBS
Dr. Harbo is a neuromuscular specialist at Aarhus University Hospital in Aarhus, Denmark, a certified Centre of Excellence by the GBS|CIDP Foundation International.
David R. Cornblath, MD
Johns Hopkins University, Baltimore, MD, USA
David R. Cornblath, MD
David R. Cornblath, MD
Johns Hopkins University, Baltimore, MD, USA
  • GBS
David R. Cornblath received his MD from Case Western Reserve University and completed his residency and fellowship at the Hospital of the University of Pennsylvania under Prof. A.K. Asbury.
What is Guillain-Barré Syndrome (GBS)?
READ MORE
What are the symptoms of GBS?
READ MORE
How is GBS treated?
READ MORE

Slides & Posters about GBS

Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
PDF | 680 KB
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
PDF | 2.2 MB
IgG Levels and Wear Off Reflect Administration and Outcome
PDF | 1.5 MB
Incidence of GBS and CIDP Following Influenza Vaccination
PDF | 155 KB
Back to Top